Top-News

AstraZeneca Aktie News

Aktie
WKN:  886455 ISIN:  GB0009895292 US-Symbol:  AZNCF Branche:  Pharmazeutika Land:  Großbritannien
156,35 €
+1,60 €
+1,03%
16:10:39 Uhr
Depot/Watchlist
Marktkapitalisierung *
237,62 Mrd. €
Streubesitz
45,40%
KGV
29,48
Dividende
0,77 £
neu: Nachhaltigkeits-Score
56 %
Index-Zuordnung
Stoxx Europe 50
Weiter aufwärts? Long handeln - Jetzt mit Hebel 20,62: MM78GV
Werbung

AstraZeneca News

09.01.25 - Newsfile
ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - January 9, 2025) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ ...
08.01.25 - Newsfile
ROSEN, NATIONAL TRIAL LAWYERS, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - January 8, 2025) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ ...
07.01.25 - Newsfile
ROSEN, A LONGSTANDING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - January 7, 2025) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ ...
07.01.25 - dpa-AFX Analyser
Berenberg belässt Astrazeneca auf 'Buy' - Ziel 14000 Pence
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Astrazeneca auf "Buy" mit einem Kursziel von 14000 Pence belassen. "Neues Jahr, neue ...
07.01.25 - dpa-AFX Analyser
Bernstein belässt Astrazeneca auf 'Outperform' - Ziel 18000 Pence
NEW YORK (dpa-AFX Analyser) - Das US-​Analysehaus Bernstein Research hat die Einstufung für Astrazeneca auf "Outperform" mit einem Kursziel von 18000 Pence belassen. ...
06.01.25 - dpa-AFX Analyser
JPMorgan belässt Astrazeneca auf 'Overweight' - Ziel 14000 Pence
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca vor Zahlen zum vierten Quartal auf "Overweight" mit einem Kursziel von 14000 Pence ...
05.01.25 - Newsfile
ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - January 5, 2025) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ ...
05.01.25 - Newsfile
AZN INVESTOR ALERT: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
San Diego, California--(Newsfile Corp. - January 5, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of AstraZeneca PLC (NASDAQ: AZN) ...
04.01.25 - Newsfile
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - January 4, 2025) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ ...
03.01.25 - Newsfile
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - January 3, 2025) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ ...
02.01.25 - Newsfile
ROSEN, A RANKED AND LEADING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - January 2, 2025) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ ...
02.01.25 - Newsfile
AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
New York, New York--(Newsfile Corp. - January 2, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has ...
01.01.25 - Newsfile
ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - January 1, 2025) - WHY:  Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of ...
31.12.24 - Newsfile
ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - December 31, 2024) - WHY:  Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of ...
30.12.24 - Newsfile
ROSEN, A TOP-RANKED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - December 30, 2024) - WHY:  Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of ...
29.12.24 - Newsfile
ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - December 29, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of ...
28.12.24 - Newsfile
ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - December 28, 2024) - WHY:  Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of ...
27.12.24 - Newsfile
ROSEN, A TOP-RANKED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - December 27, 2024) - WHY:  Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of ...
26.12.24 - Newsfile
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - December 26, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of ...
25.12.24 - Newsfile
ROSEN, LEADING INVESTOR COUNSEL Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
New York, New York--(Newsfile Corp. - December 25, 2024) - WHY:  Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of ...

Newssuche

Videos

newspaper
08.12.25 +4,91%
Technical Trading: Die besten 3 Tage
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »